3-D Matrix Ltd – Strategy, SWOT and Corporate Finance Report
- Pages: 33
- Published: November 2018
- Report Code: MLPH183959FSA
3-D Matrix Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.
3-D Matrix Ltd (3-D Matrix) is a regenerative medicine company that focuses at commercializing its self-assembling peptide technology. It develops medical products by applying this technology under a license granted by Massachusetts Institute of Technology (MIT). The technology finds applications in the field of surgical and medical regenerative medicine, cell therapy and drug discovery. 3-D Matrix's lead product, PuraMatrix caters to periodontal bone regeneration. The company has several collaborative agreements with academic research institutions, enterprises and medical institutions. The company operates across the US, France, the Netherlands, China and Singapore. 3-D Matrix is headquartered in Chiyoda-ku, Tokyo, Japan.
Scope
Detailed information on 3-D Matrix Ltd required for business and competitor intelligence needs
A study of the major internal and external factors affecting 3-D Matrix Ltd in the form of a SWOT analysis
An in-depth view of the business model of 3-D Matrix Ltd including a breakdown and examination of key business segments
News about 3-D Matrix Ltd, such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
Gain understanding of 3-D Matrix Ltd and the factors that influence its strategies.Track strategic initiatives of the company and latest corporate news and actions.
Assess 3-D Matrix Ltd as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on 3-D Matrix Ltds business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
PharmaDesign Inc
Kaketsuken
CellSeed Inc
Capital Genomix, Inc
Aushon BioSystems Inc
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.